The Global Pre-filled Syringe Market 2014-2024 report analyses how
this important sub-sector will continue to grow across the next decade. The
report highlights key companies, geographies and products that we believe will
deliver double digit growth across the next decade.
Buy this report today and acquire analysis of the state of the
pre-filled syringes market in 2014 and a market forecastfor the period
2014-2024. Market forecasts are also provided for global pre-filled syringes
for glass and plastics on the global level (value and volume) as well as for
the geographic regions of key pre-filled syringe types (value and volume).
The advantages that will drive the growth of pre-filled syringes include
ease of administration, improved safety, reduced risk of contamination,
elimination of medication errors, low incidence of needlestick injuries,
accurate dosing and reduction in medical expenditure due to reduced visits to
healthcare facilities.
When compared to standard injectables, the pre-filled syringes market
is still evolving, and its use is slowly increasing. Developed countries have
shown a strong adoption rate for pre-filled syringes whereas developing &
ROW countries have often been slow in adopting this technology. During the
forecast period, however, the adoption rate will witness a healthy growth in
emerging markets, and will witness a growth rate above that of developed
geographies such as the US and in Europe.
The market is highly consolidated and is currently dominated by key
global players such as Abbott Labs, Becton Dickinson, Baxter, Nipro
Corporation, Schott, Gerresheimer, West Pharmaceutical, Ypsomed, Bespak and
Unilife Corporation. Other companies such as Haselmeier; Weigao Group, Nuova
Ompi (Stevanato Group), Owen Mumford and Vetter Pharma are likely to foster
innovation in the coming years.
The Global Pre-filled Syringe Market 2014-2024 report includes over
125 tables, charts and graphs quantifying and forecasting the market in detail.
In addition, the report offers 14 profiles of the leading PFS companies in the
market alongside 3 expert interviewees offering key insights into the state of
the market currently and in the future;
- Schott Kaisa
- West Pharmaceuticals
- Fresenius Kabi
Spanning over 160 pages, “The
Global Pre-Filled Syringe Market to 2024” report covering the Executive
Summary, Introduction to the Pre Filled Syringe Market, Global Pre-Filled
Syringe; Market Revenue and Volume Forecasts to 2024, Key Geographies in the
Global Pre-Filled Syringe Market 2014-2024, Leading Therapeutic Segments for
Pre-Filled Syringes 2013-2024, SWOT Analysis of the Global Pre-Filled Syringes
Market 2014-2024, Company Profiles, Expert Opinion. The report covered
companies are - Abbott Labs, AbbVie, Aesica, AesRX LLC (Part of Baxter
International), Amgen, Antares Pharma Inc., Bausch, Baxter, Bayer, Becton
Dickinson, Berlin-Chemie, Biocon, Biogen Idec, Biogen Inc., Biosensors
International Group, BMS
For
further information on this report, please visit- http://mrr.cm/45M
Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices
No comments:
Post a Comment
Note: only a member of this blog may post a comment.